Preprint Article Version 1 This version is not peer-reviewed

Molecular Docking, Computational and Antithrombotic Studies of Novel 1,3,4-oxadiazole Derivatives

Version 1 : Received: 27 August 2018 / Approved: 27 August 2018 / Online: 27 August 2018 (14:54:10 CEST)

A peer-reviewed article of this Preprint also exists.

Batool, M.; Tajammal, A.; Farhat, F.; Verpoort, F.; Khattak, Z.A.K.; Mehr-un-Nisa; Shahid, M.; Ahmad, H.A.; Munawar, M.A.; Zia-ur-Rehman, M.; Asim Raza Basra, M. Molecular Docking, Computational, and Antithrombotic Studies of Novel 1,3,4-Oxadiazole Derivatives. Int. J. Mol. Sci. 2018, 19, 3606. Batool, M.; Tajammal, A.; Farhat, F.; Verpoort, F.; Khattak, Z.A.K.; Mehr-un-Nisa; Shahid, M.; Ahmad, H.A.; Munawar, M.A.; Zia-ur-Rehman, M.; Asim Raza Basra, M. Molecular Docking, Computational, and Antithrombotic Studies of Novel 1,3,4-Oxadiazole Derivatives. Int. J. Mol. Sci. 2018, 19, 3606.

Journal reference: Int. J. Mol. Sci. 2018, 19, 3606
DOI: 10.3390/ijms19113606

Abstract

A new series of 1,3,4-oxadiazoles derivatives was synthesized, characterized and evaluated for their in vitro and in vivo anti-thrombotic activity. Compounds (3a-3i) exhibited significant clot lysis with respect to negative control and reference drug streptokinase (30,000 IU) while enhanced clotting time (CT) values were observed (130-342 sec) for these tested compounds than the standard drug heparin (110 sec.). High affinity towards 1NFY with greater docking score was observed for the compounds (3a, 3i, 3e, 3d and 3h) than the control ligand RPR200095. In addition, very good inhibitory potential against factor Xa (F-Xa) was observed with higher docking scores (5612-6270) with ACE values (–189.68 to –352.28 kcal/mol) than the control ligand RPR200095 (Docking score 5192; ACE –197.81 kcal/mol. In vitro, in vivo and in silico results proposed that these newly synthesized compounds can be used as anti-coagulant agents.

Subject Areas

Factor Xa ( F-Xa), Cardiovascular diseases (CD), Coronary heart disease (CHD), Tissue plasminogen activator (t-PA), Urokinase (UK), Streptokinase (SK), N,N-Dimethyl formamide (DMF)

Readers' Comments and Ratings (0)

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.